Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2019
Reporting Period: Quarter ended March 31, 2019
Status: Emerging Growth Company (Elected not to use extended transition period for new accounting standards)
Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release regarding the quarter ended March 31, 2019. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained in the unaudited condensed consolidated financial statements and press release furnished as Exhibit 99.1, which are incorporated by reference but not reproduced in this document.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text of the 8-K. It directs investors to the press release (Exhibit 99.1) for the announcement of earnings and other disclosures.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on May 8, 2019, announcing earnings and making other disclosures.
Legal Status of Information: Information in Item 2.02, including the press release, is furnished pursuant to Item 2.02 of Form 8-K and is not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific revenue and net income figures in the press release (Exhibit 99.1) as they are not listed in the 8-K text.
- Confirm the Company's status as an Emerging Growth Company and its election regarding accounting standard transition periods.
- Note that the financial data in this filing is unaudited.
- Review the full press release for any forward-looking statements or guidance not summarized in this report.